Published in Am J Kidney Dis on July 15, 2015
Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76
The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol (2016) 0.75
Epidemiology of low-proteinuric chronic kidney disease in renal clinics. PLoS One (2017) 0.75
Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study. BMC Nephrol (2016) 0.75
Obesity and kidney disease: Hidden consequences of the epidemic. Indian J Nephrol (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Clin Kidney J (2017) 0.75
Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. Kidney Int (2017) 0.75
Obesity and kidney disease: hidden consequences of the epidemic. Pediatr Nephrol (2017) 0.75
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Kidney Dis (Basel) (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05
Body mass index and risk for end-stage renal disease. Ann Intern Med (2006) 7.56
Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45
Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw (2006) 7.19
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) (2013) 2.50
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis (2005) 2.05
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Obesity and hypertension prevalence in populations of African origin. The Investigators of the International Collaborative Study on Hypertension in Blacks. Epidemiology (1996) 1.91
Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol (2003) 1.70
Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant (2012) 1.59
Determinants of hypertension in West Africa: contribution of anthropometric and dietary factors to urban-rural and socioeconomic gradients. Am J Epidemiol (1996) 1.52
Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation (1996) 1.40
Associations of fat distribution and obesity with hypertension in a bi-ethnic population: the ARIC study. Atherosclerosis Risk in Communities Study. Obes Res (2000) 1.35
Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant (2009) 1.28
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag (2009) 1.22
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. Kidney Int (2005) 1.13
Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) (2008) 1.11
The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int (2009) 1.08
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res (2011) 1.06
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract (2009) 1.03
Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring) (2010) 0.97
The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97
Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study. Diabetes Care (2009) 0.96
Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int (2014) 0.95
Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur J Cardiovasc Prev Rehabil (2007) 0.90
Body mass index and the risk of progression of chronic kidney disease. J Ren Nutr (2011) 0.83
Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol (2014) 0.75
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2014) 2.85
Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. Circulation (2013) 1.52
Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk. J Am Soc Hypertens (2013) 0.81
Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Diabetes Care (2015) 0.81
White-Coat Effect Among Older Adults: Data From the Jackson Heart Study. J Clin Hypertens (Greenwich) (2015) 0.78
Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study". Circulation (2016) 0.75
Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg. Circulation (2017) 0.75
Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study. Circulation (2017) 0.75
Does the Association of Diabetes With Stroke Risk Differ by Age, Race, and Sex? Results From the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Diabetes Care (2019) 0.75
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis (2017) 0.75